Bellecapital International Ltd. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 8.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,614 shares of the healthcare conglomerate’s stock after purchasing an additional 858 shares during the period. UnitedHealth Group makes up 1.8% of Bellecapital International Ltd.’s portfolio, making the stock its 17th biggest holding. Bellecapital International Ltd.’s holdings in UnitedHealth Group were worth $5,866,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. TimeScale Financial Inc. grew its position in shares of UnitedHealth Group by 276.9% during the 3rd quarter. TimeScale Financial Inc. now owns 49 shares of the healthcare conglomerate’s stock valued at $25,000 after purchasing an additional 36 shares in the last quarter. Pflug Koory LLC grew its position in UnitedHealth Group by 160.0% in the third quarter. Pflug Koory LLC now owns 52 shares of the healthcare conglomerate’s stock worth $26,000 after acquiring an additional 32 shares in the last quarter. Urban Wealth Management LLC purchased a new position in UnitedHealth Group in the second quarter worth $29,000. Knott David M Jr purchased a new position in UnitedHealth Group in the second quarter worth $29,000. Finally, Belmont Capital LLC grew its position in UnitedHealth Group by 294.1% in the third quarter. Belmont Capital LLC now owns 67 shares of the healthcare conglomerate’s stock worth $34,000 after acquiring an additional 50 shares in the last quarter. 86.31% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
UNH has been the subject of several recent research reports. Morgan Stanley reissued an “overweight” rating and issued a $587.00 price target on shares of UnitedHealth Group in a research note on Wednesday, November 23rd. SVB Leerink lowered their price target on shares of UnitedHealth Group from $625.00 to $618.00 and set an “outperform” rating for the company in a research note on Monday, October 17th. UBS Group lowered their price target on shares of UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating for the company in a research note on Wednesday, January 18th. Credit Suisse Group upped their price objective on shares of UnitedHealth Group from $590.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, December 7th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of UnitedHealth Group from $615.00 to $617.00 and gave the company a “buy” rating in a research note on Tuesday. Three analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $599.39.
UnitedHealth Group Stock Up 0.2 %
UNH traded up $1.15 during midday trading on Wednesday, reaching $492.75. The company’s stock had a trading volume of 239,208 shares, compared to its average volume of 3,928,426. The firm has a market capitalization of $460.40 billion, a price-to-earnings ratio of 23.20, a PEG ratio of 1.36 and a beta of 0.73. The company has a current ratio of 0.77, a quick ratio of 0.82 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 1 year low of $445.73 and a 1 year high of $558.10. The stock’s 50-day moving average is $518.45 and its 200-day moving average is $524.08.
UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings data on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share for the quarter, topping analysts’ consensus estimates of $5.17 by $0.17. The business had revenue of $82.79 billion for the quarter, compared to analysts’ expectations of $82.53 billion. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The business’s revenue was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $4.48 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 24.9 EPS for the current year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, December 13th. Stockholders of record on Monday, December 5th were issued a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend was Friday, December 2nd. UnitedHealth Group’s payout ratio is 31.15%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.